U.S. Urea Cycle Disorders Treatment Market Is Estimated To Witness High Growth Owing To Horizon Therapeutics Plc and Bausch Health Companies Inc
The U.S. Urea Cycle Disorders Treatment market is estimated to be valued at US$ 510.0 million in 2023 and is expected to exhibit a CAGR of 3.56% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Urea cycle disorders refer to a group of rare genetic disorders that affect the body's ability to eliminate waste nitrogen. These...
0 Commenti 0 condivisioni 2K Views 0 Anteprima
Sponsorizzato